1 t bloody stools with fever, prostration, and abdominal cramps.

2 es, which include bloody diarrhea and severe abdominal cramps.

3 ents reported nausea (95%), dizziness (72%), abdominal cramps (58%), headache (52%), vomiting (51%),

4           Patients reported diarrhea (100%), abdominal cramps (93%), fever (93%), bloody stools (72%)

5                      One patient experienced abdominal cramps and diarrhea necessitating interruption

6 stinal symptoms, including emesis, diarrhea, abdominal cramping, and gastrointestinal bleeding.

7 itis was admitted to the hospital because of abdominal cramping, diarrhea, hematochezia, fever to a p

8 , menstrual disturbances, breast tenderness, abdominal cramping, dizziness, headache, and mood change

9 ts on arm 1 had significantly (P < .05) more abdominal cramps, fatigue, transient hearing loss, febri

10 s were observed except for mild diarrhea and abdominal cramping in the infusion group on the infusion

11 iting toxicity was grade 3/4 diarrhea and/or abdominal cramps in six of 12 patients treated at 24 mg/

12        The most common side effect was lower abdominal cramping/pain (P = .01).

13 companied by manifestations including fever, abdominal cramps, tenesmus, and malaise.

14 For specific GI symptoms (eg, gas, diarrhea, abdominal cramping), there were no significant differenc

15                         Grade 0, 1, 2, and 3 abdominal cramps were observed in 32%, 45%, 21%, and 2%

16 d measure of diarrhea, nausea, vomiting, and abdominal cramps, were recorded.